Search

Your search keyword '"Masarone D"' showing total 151 results

Search Constraints

Start Over You searched for: Author "Masarone D" Remove constraint Author: "Masarone D"
151 results on '"Masarone D"'

Search Results

2. Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry

3. How to fill the gap in the symptomatic HF patient journey between optimal medical therapy and advanced heart failure treatment: two Italian surveys

4. C53 EFFECTS OF CARDIAC CONTRACTILITY MODULATION THERAPY ON LEFT VENTRICLE GLOBAL LONGITUDINAL STRAIN AND MYOCARDIAL MECHANO–ENERGETIC EFFICIENCY IN PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION

5. Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry

6. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

8. Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure

9. Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry

10. Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry

11. Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry

13. European Cardiomyopathy Pilot Registry : EURObservational Research Programme of the European Society of Cardiology

15. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)

16. Cardiac resynchronization therapy in cardiomyopathies

17. European cardiomyopathy pilot registry: EURObservational research programme of the European society of cardiology

19. Heart failure: molecular, genetic and epigenetic features of the disease

20. La Morte Cardiaca Improvvisa: cosa il cardiologo deve sapere (Sudden Cardiac Death: what a cardiologist should know)

22. Nuove prospettive nella terapia dello scompenso cardiaco: Farmacogenetica, Farmacogenomica e terapia cellulare

23. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD)

24. RUOLO DELLA ADIPOCHINA RESISTINA NELL'INDUZIONE DELL'ESPRESSIONE DELLE MOLECOLE DI ADESIONE DA PARTE DI CELLULE ENDOTELIALI DI ARTERIA CORONARICA UMANA

25. La resistina è un’ adipocitochina in grado di indurre l’ espressione del fattore tissutale da parte di cellule endoteliali prelevate da arterie coronariche umane

26. Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group

28. [The role of natriuretic peptides in heart failure]

32. Comorbidities in chronic heart failure: An update from Italian Society of Cardiology (SIC) Working Group on Heart Failure

33. Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?

34. Prevalence and clinical significance of red flags in patients with hypertrophic cardiomyopathy

35. Add-on Therapy With Sacubitril/Valsartan and Clinical Outcomes in CRT-D Nonresponder Patients

36. Beta-blockers in pulmonary arterial hypertension: Time for a second thought?

37. Prevalence and clinical implications of hyperhomocysteinaemia in patients with hypertrophic cardiomyopathy and MTHFR C6777T polymorphism

38. Epidemiology and Clinical Aspects of Genetic Cardiomyopathies

39. Berlin Heart EXCOR® pediatric ventricular assist device in a patient with Sotos syndrome: a case report

40. Diagnostic clues for the diagnosis of nonsarcomeric hypertrophic cardiomyopathy (Phenocopies): Amyloidosis, fabry disease, and mitochondrial disease

41. Exercise speckle-tracking strain imaging demonstrates impaired right ventricular contractile reserve in hypertrophic cardiomyopathy

42. Genetics of Takotsubo Syndrome

43. Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group

44. Renal function and peak exercise oxygen consumption in chronic heart failure with reduced left ventricular ejection fraction

45. Pathogenesis of Takotsubo Syndrome

46. Right Ventricular Cardiomyopathies: A Multidisciplinary Approach to Diagnosis

47. Natriuretic peptides: molecular biology, pathophysiology and clinical implications for the cardiologist

48. Takotsubo Cardiomyopathy Do the Genetics Matter?

49. Mitochondrial diseases and the heart: an overview of molecular basis, diagnosis, treatment and clinical course

50. Effect of cardiac resynchronization therapy on cardiotrophin-1 circulating levels in patients with heart failure

Catalog

Books, media, physical & digital resources